Cargando…
Cell-mediated cytotoxicity as a result of immunotherapy in patients with acute myeloid leukaemia.
Leucocytes from normal individuals and from patients with acute myeloid leukaemia (AML) in remission receiving active immunotherapy with allogeneic AML blasts (AML-I) were cultured for 6 days with AML-I blasts, Burkitt's lymphoma cells (BL) or lymphoblastoid cells (LCL). The leucocytes were the...
Autores principales: | Taylor, G. M., Harris, R., Freeman, C. B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1976
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2024940/ https://www.ncbi.nlm.nih.gov/pubmed/1063029 |
Ejemplares similares
-
Proceedings: Cell mediated cytotoxicity (CMC) in patients with acute myeloblastic leukaemia receiving immunotherapy.
por: Taylor, G. M., et al.
Publicado: (1975) -
Proceedings: Active immunotherapy in acute myeloid leukaemia.
por: Freeman, C. B., et al.
Publicado: (1975) -
In vitro stimulation of cell-mediated cytotoxicity by acute leukaemias.
por: Taylor, G. M.
Publicado: (1981) -
Antigenic Targets for the Immunotherapy of Acute Myeloid Leukaemia
por: Khan, Ghazala Naz, et al.
Publicado: (2019) -
Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions.
por: Harris, R., et al.
Publicado: (1978)